首页> 外文期刊>Experimental Biology and Medicine: Journal of the Society for Experimental Biology and Medicine >The focal segmental glomerulosclerosis permeability factor: biochemical characteristics and biological effects.
【24h】

The focal segmental glomerulosclerosis permeability factor: biochemical characteristics and biological effects.

机译:局灶节段性肾小球硬化通透性因子:生化特征和生物学作用。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Focal segmental glomerulosclerosis (FSGS) is characterized by steroid resistant nephrotic syndrome and progression to end-stage renal disease. Proteinuria in certain patients with FSGS may be caused by a circulating factor (FSGS permeability factor [FSPF]). The current report documents the biochemical characteristics and the biological and molecular effects of 70% ammonium sulfate supernatant of plasma from patients with recurrence of FSGS after transplantation (FSGS 70% supernatant). FS permeability activity, defined as the capacity of plasma from patients with FSGS to increase albumin permeability (P(alb)) of isolated glomeruli, was assessed in vitro. Permeability activity was not affected by lyophilization. FSPF bound strongly to matrices containing Mono-Q anion exchanger or protein A. It eluted from matrix-bound Cibacron blue F3GA over a wide range of salt concentrations, indicating a potential binding with other proteins, such as albumin. FSPF caused a maximal increase in P(alb) within 2 mins of incubation in vitro. Cellular proteins isolated from glomeruli with increased P(alb) showed decreased tyrosine phosphorylation of focal adhesion kinase, paxillin, and other proteins. Tyrosine phosphatase ]inhibition prevented the increase in P(alb). Intravenous administration of as little as 3 mg protein in FSGS 70% supernatant increased P(alb), while 9 mg or more were required to produce proteinuria. We conclude that FSPF is a low-molecular-weight protein, carries an anionic charge, and binds to protein A. Effects of FSPF on the glomerular permeability barrier are rapid and dose dependent and involve signaling through altered phosphorylation of cellular proteins. Identification of these biochemical and biological characteristics may be used to design strategies for removing FSPF from circulation and for purification and identification of this factor.
机译:局灶性节段性肾小球硬化症(FSGS)的特征是类固醇抵抗性肾病综合征和进展为终末期肾脏疾病。某些FSGS患者的蛋白尿可能是由循环因子(FSGS通透性因子[FSPF])引起的。本报告记录了移植后复发FSGS患者的血浆中70%硫酸铵上清液(FSGS 70%上清液)的生化特性以及生物学和分子效应。体外评估了FS通透性活性,其定义为来自FSGS患者的血浆增加分离的肾小球的白蛋白通透性(P(alb))的能力。渗透活性不受冻干的影响。 FSPF与含有Mono-Q阴离子交换剂或蛋白A的基质牢固结合。它在宽范围的盐浓度下从与基质结合的Cibacron蓝F3GA洗脱,表明与其他蛋白(如白蛋白)的潜在结合。 FSPF在体外孵育2分钟内引起P(alb)的最大增加。从肾小球中分离出的具有增加的P(alb)的细胞蛋白显示出粘着斑激酶,帕西林和其他蛋白的酪氨酸磷酸化降低。酪氨酸磷酸酶]抑制阻止了P(alb)的增加。 FSGS 70%上清液中静脉内施用低至3 mg的蛋白会增加P(alb),而产生蛋白尿需要9 mg或更多。我们得出的结论是,FSPF是一种低分子量蛋白质,带有阴离子电荷,并与蛋白质A结合。FSPF对肾小球通透性屏障的作用是快速且剂量依赖性的,并且涉及通过改变细胞蛋白质的磷酸化而产生的信号。这些生化和生物学特性的鉴定可用于设计从循环中去除FSPF以及纯化和鉴定该因子的策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号